Epiterna
PrivateLast Round
Seed
Aug 1, 2023
Total Funding Raised
$10.97M
Company Overview
Epiterna is a biotechnology company that provides products and research to slow the aging process and extend the lifespan of animals and humans.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
longevity therapeuticsdrug discovery platformhigh-throughput screeningdrug repurposingaging as a diseasegerosciencepet longevityanti-aginghealthy lifespan extensionsmall molecule drugscanine longevityAI drug discoveryContract Research OrganizationCROanimal healthaging clocks
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epiterna Comps
Public and private peers based on sector, stage, and business model.
Epiterna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2023 |
Epiterna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prima Materia | Seed |
Epiterna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epiterna's valuation, stock price, and market status.
